首页> 外文期刊>Journal of molecular graphics & modelling >Molecular modeling study of CP-690550 derivatives as JAK3 kinase inhibitors through combined 3D-QSAR, molecular docking, and dynamics simulation techniques.
【24h】

Molecular modeling study of CP-690550 derivatives as JAK3 kinase inhibitors through combined 3D-QSAR, molecular docking, and dynamics simulation techniques.

机译:CP-690550衍生物作为JAK3激酶抑制剂通过组合3D-QSAR,分子对接和动力学模拟技术的分子建模研究。

获取原文
获取原文并翻译 | 示例
       

摘要

To develop more potent JAK3 kinase inhibitors, a series of CP-690550 derivatives were investigated using combined molecular modeling techniques, such as 3D-QSAR, molecular docking and molecular dynamics (MD). The leave-one-out correlation (q(2)) and non-cross-validated correlation coefficient (r(2)) of the best CoMFA model are 0.715 and 0.992, respectively. The q2 and r2 values of the best CoMSIA model are 0.739 and 0.995, respectively. The steric, electrostatic, and hydrophobic fields played important roles in determining the inhibitory activity of CP-690550 derivatives. Some new JAK3 kinase inhibitors were designed. Some of them have better inhibitory activity than the most potent Tofacitinib (CP-690550). Molecular docking was used to identify some key amino acid residues at the active site of JAK3 protein. 10 ns MD simulations were successfully performed to confirm the detailed binding mode and validate the rationality of docking results. The calculation of the binding free energies by MMPBSA method gives a good correlation with the predicted biological activity. To our knowledge, this is the first report on MD simulations and free energy calculations for this series of compounds. The combination results of this study will be valuable for the development of potent and novel JAK3 kinase inhibitors. (C) 2017 Elsevier Inc. All rights reserved.
机译:为了开发更多有效的JAK3激酶抑制剂,使用组合的分子建模技术研究了一系列CP-690550衍生物,例如3D QSAR,分子对接和分子动力学(MD)。最佳COMFA模型的休留次相关(Q(2))和非交叉验证的相关系数(R(2))分别为0.715和0.992。最佳COMSIA模型的Q2和R2值分别为0.739和0.995。在确定CP-690550衍生物的抑制活性时,空间,静电和疏水性领域起到了重要作用。设计了一些新的JAK3激酶抑制剂。其中一些比最有效的Tofacitinib(CP-690550)具有更好的抑制活性。分子对接用于鉴定JAK3蛋白的活性位点处的一些关键氨基酸残基。成功执行10 ns MD模拟以确认详细的绑定模式并验证对接结果的合理性。通过MMPBSA方法计算粘合性能量与预测的生物活性呈良好的相关性。据我们所知,这是该系列化合物的MD模拟和自由能计算的第一个报告。该研究的组合结果对于开发有效和新型JAK3激酶抑制剂是有价值的。 (c)2017年Elsevier Inc.保留所有权利。

著录项

  • 来源
  • 作者单位

    Shanghai Inst Technol Sch Chem &

    Environm Engn Haiquan Rd 100 Shanghai 201418 Peoples R China;

    Shanghai Inst Technol Sch Chem &

    Environm Engn Haiquan Rd 100 Shanghai 201418 Peoples R China;

    Shanghai Inst Technol Sch Chem &

    Environm Engn Haiquan Rd 100 Shanghai 201418 Peoples R China;

    Shanghai Inst Technol Sch Chem &

    Environm Engn Haiquan Rd 100 Shanghai 201418 Peoples R China;

    Shanghai Inst Technol Sch Chem &

    Environm Engn Haiquan Rd 100 Shanghai 201418 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;计算技术、计算机技术;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号